Department of Physiotherapy, Applied Science Private University, Amman 11931, Jordan.
Department of Physiotherapy, School of Rehabilitation Sciences, The University of Jordan, Amman 11942, Jordan.
Medicina (Kaunas). 2024 Jul 18;60(7):1161. doi: 10.3390/medicina60071161.
: Robotics is commonly used in the rehabilitation of neuro-musculoskeletal injuries and diseases. While in these conditions, robotics has clear benefits, it is unknown whether robotics will also enhance the outcome of cardiac rehabilitation. This systematic review evaluates the use of robotics in cardiac rehabilitation. : A systematic literature search was conducted using PubMed (MEDLINE), CINAHL, AMED, SPORTDiscus, and the Physiotherapy Evidence Database. Longitudinal interventional studies were included if they met specified criteria. Two reviewers independently conducted title, abstract, and full-text screening and data extraction. The quality assessment and risk of bias were conducted according to the PEDRO scale and Cochrane Risk of Bias tool 2, respectively. : Four trials were included in this review out of 60 screened studies. The quality of the included studies was good with a low risk of bias. The trials used different robotic systems: Lokomat system, Motomed Letto/Thera Trainer tigo, BEAR, and Myosuit. It was found that interventions that included the use of robotic assistance technologies improved the exercise capacity, VO max/peak, left ventricular ejection fraction, QOL, and physical functioning in people with cardiac diseases. : Robotic assistance technologies can be used in cardiac rehabilitation programs. Further studies are needed to confirm the results and determine whether the use of robotics enhances intervention outcomes above standard interventions.
机器人技术常用于神经肌肉骨骼损伤和疾病的康复。虽然在这些情况下机器人技术具有明显的优势,但尚不清楚机器人技术是否也会改善心脏康复的效果。本系统评价评估了机器人技术在心脏康复中的应用。
系统地检索了 PubMed(MEDLINE)、CINAHL、AMED、SPORTDiscus 和 Physiotherapy Evidence Database 中的文献。如果符合特定标准,将纳入纵向干预研究。两名审查员独立进行标题、摘要和全文筛选以及数据提取。根据 PEDRO 量表和 Cochrane 偏倚风险工具 2 分别进行质量评估和偏倚风险评估。
在筛选出的 60 项研究中,有 4 项试验被纳入本综述。纳入研究的质量良好,偏倚风险低。这些试验使用了不同的机器人系统:Lokomat 系统、Motomed Letto/Thera Trainer tigo、BEAR 和 Myosuit。研究发现,包括使用机器人辅助技术的干预措施可以提高患有心脏病的人的运动能力、VO max/峰值、左心室射血分数、生活质量和身体机能。
机器人辅助技术可用于心脏康复计划。需要进一步的研究来确认这些结果,并确定机器人技术的使用是否能提高干预效果,超过标准干预。